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ABSTRACT
Adolescence is a vulnerable developmental stage where significant changes occur 
in a youth’s body, brain, environment and socialization, which may increase 
vulnerability to substance use, development of addiction, and psychiatric disorders. 
A co-occurrence of mental and behavioral disturbances with drug involvement in 
adolescence is common, as reflected in both a high risk for drug use in youth with 
mental illness and a high frequency of psychopathology among drug users. In this 
review we provide a broad and basic overview of some of the research evidence 
indicating a strong co-occurrence of drug use disorders (abuse and dependence) 
with externalizing and internalizing disorders, as well as a few other serious mental 
health conditions among adolescents. Increasing awareness and knowledge of the 
high probability of the co-occurrence of mental and behavioral disturbances with 
drug involvement informs the understanding of the etiology, course, and treatment 
of psychiatric problems among adolescents.
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INTRODUCTION 
Adolescence is a critical and vulnerable stage of development where 
significant changes occur in a youth’s body, brain, environment and 
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socialization, which may increase vulnerability to substance use, develop-
ment of addiction and psychiatric disorders. The onset of substance use and 
mental and behavioral disturbances occurs for many during the adolescent 
years. Alcohol and nicotine obtained via the use of tobacco products are 
often the first and most frequently used substances among youth. Nicotine 
is fre quently used repeatedly on a daily basis and risky or excessive alcohol 
consumption is a problem for some. Cannabis is one of the most commonly 
used illegal drugs among youth in the United States and in other countries, 
but rates of nonmedical use of prescription (pain relievers, tranquilizers, 
stimulants, and depressants) and over-the-counter medications are also 
alarming.1 For many, substance use transitions into developing problems 
associated with the use. The National Comorbidity Survey-Adolescent 
Supplement (NCS-A) conducted in the US between 2001 and 2004 
estimates that approximately 36.6 percent of adolescent drug users meet 
criteria for substance abuse with or without dependence,2 19.6 percent of 
smokers meet criteria for nicotine dependence,3 and 27.5 percent of 
adolescent regular alcohol users developed alcohol abuse with or without 
dependence.2 This same survey also estimates that nearly half of American 
youth meet lifetime criteria for at least one psychiatric disorder, with half 
of these associated with severe impairment.4 Anxiety disorders were the 
most common condition (31.9%), followed by behavior disorders (19.1%), 
mood disorders (14.3%), and substance use disorders (SUDs) (11.4%).
Involvement with substances and mental and behavioral disturbances 
often co-occur among adolescents as reflected in both a high risk for 
substance use in youth with mental illness and a high frequency of psycho-
pathology among substance users. One literature review of community 
studies estimated that 60 percent of youths involved with drugs had a 
comorbid psychiatric diagnosis.5 In addition, the evidence from extensive 
study of comorbidity of SUDs and psychiatric disorders among adult samples 
highlights the importance of the need to understand the onset and progression 
of psychiatric and substance use problems and disorders among youth.6-8 
In this review we describe a framework often used for psychiatric 
disorders among adolescents, and then address some of the strengths and 
weaknesses of the research currently being used to study the comorbidity of 
SUDs and other psychiatric disorders. We then follow with a broad overview 
of some of the research evidence indicating a strong co-occurrence of SUDs 
with externalizing and internalizing disorders, as well as a few other serious 
mental health conditions among adolescents. After briefly describing some 
possible explanations for the comorbid condition, this review ends with 
recommendations for continued research to aid prevention and intervention 
efforts. The goal of this review is not to be exhaustive but to highlight the 
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complexity of issues faced by researchers and the importance of the need to 
understand the phenomenon of comorbidity during the stage of life when 
these disorders emerge. Increasing awareness and knowledge of the high 
probability of the co-occurrence of mental and behavioral disturbances 
with substance use involvement can inform the understanding of the 
etiology, course, and treatment of psychiatric problems among adolescents. 
DISCUSSION
One common theoretical framework for understanding psychiatric disorders 
among adolescents is the internalizing and externalizing model.9 
Internalization is the propensity to express distress inwards. Common intern-
alizing disorders during adolescence include mood disorders such as major 
depressive disorder (MDD), dysthymia, and anxiety disorders including 
generalized anxiety disorder, separation anxiety disorder, phobias, and 
obsessive-compulsive disorder. Conversely, the propensity to express distress 
outwards is known as externalization. Disruptive behavior disorders such as 
attention-deficit/hyperactivity disorder (ADHD), oppositional defiant 
disorder, and conduct disorder (CD) are common externalizing disorders 
during adolescence. SUDs also fall under the category of disruptive behavior 
disorders, but for this review we address the comorbid condition co-occurring 
with one or more of other externalizing or internalizing disorders, thus 
known as a dual diagnosis. Factor analytic studies suggest distinctions 
between internalizing and externalizing disorders,10-13 however, evidence 
also suggests a high co-occurrence between as well as among these disorders 
in adolescence.11-14 It appears that psychopathology cannot be reduced to a 
simple structure. Patterns are influenced by gender, age, persistence, and the 
constellation of diagnoses included.15,16 These inconsistent patterns might be 
a key to understanding the associations and sequencing across disorders.17 
Since comorbidity implies that two disorders occur in the same individual 
simultaneously or sequentially, and that the interactions between the two 
disorders can affect the course and prognosis of either disorder, many studies 
have attempted to quantify and establish the temporal ordering of the 
comorbidity between SUDs and psychiatric disorders among youth. However, 
differences in the research design, samples, the assessment procedure and 
criteria used to identify ‘cases’, and other assessment issues (e.g., different 
informants, timeframe captured) often result in a wide variation of estimates 
and a limited depiction of the interplay and sequencing of symptoms and 
disorder development. Below we highlight some of the research issues faced 
by those studying comorbidity in adolescents and illustrate the diversity of 
research approaches taken by several selected studies.
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Research designs and samples
The most common study design used in the field of comorbidity research is 
the cross-sectional study. Cross-sectional studies report a strong positive 
association between substance use and psychiatric disorders but rely heavily 
on accurate recall or use participants of different ages to estimate the 
probable inter-relatedness and temporality. Retrospective lifetime pre-
valence may under-estimate how common psychiatric disorders are.18 
Therefore, ideally to determine the comorbid relationship and order of onset 
of the disorders, researchers need to use prospective, longitudinal studies, in 
which adolescents are followed over long periods of time and monitored for 
the development of the disorders under investigation. A disadvantage to 
studying comorbidity using cohort studies is that they must be very large 
and have long follow-up time to accrue a sufficient numbers of cases.
The context of where the sample is drawn from and sample characteristics 
are important to consider in interpreting results and of course extremely 
important for generalization purposes. Policy and other environmental and 
social factors (e.g., taxation, minimum age laws, cultural morals and 
sanctions) can influence the availability and access to substances, thus 
patterns of specific substance use and SUD trajectories can vary among 
youth in different countries and even regions of a country. In addition, 
differences in the co-occurring rates and patterns of substance use and 
mental health problems have been found to vary by sex and age.19-22
Adolescents with comorbid disorders can be easily found in treatment 
facilities; an estimated 70 to 80 perent of youth seeking substance abuse 
treatment have one or more comorbid disorder.23 Strengths of studies 
coming from clinical sites often include the rigorous assessments of not 
only a broader array of disorders, but also, of diagnoses that conform to the 
structure of the International Classification of Diseases (ICD) and Diag-
nostic and Statistical Manual of Mental Disorders (DSM) systems. They 
are especially useful when exploring comorbidity with less common 
specific disorders (e.g., Obsessive-Compulsive Disorder). However, clinical 
samples cannot provide unbiased rates or estimates of risk factors for 
comorbidity as many youth do not receive treatment or are not treated in 
clinical settings. Individuals seeking help often have more severe symptom-
ology, and more impairment than those who do not seek treatment. To 
reduce the potential for selection biases, it is also important to evaluate the 
comorbid relationship in general population samples. 
Many population based epidemiologic studies conducted in the US, 
including some prospective longitudinal studies, have utilized regional 
samples, and findings may not be generalizable to the general adolescent 
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US population (e.g., Great Smokey Mountains Study of Youth; Oregon 
Adolescent Depression Project; Teen Health 2000).19,24-26 Indicators of 
mental health are included in several US national surveys of youth,27-31 
however the range of psychiatric disorders and identification of SUD, not 
only use, has been limited until recently. A main objective of the NCS-A 
was to provide empirical data of a wide range of psychiatric disorders from 
a nationally representative sample of US children and adolescents.32 
Researchers from other countries have also shed evidence on the co- 
occurrence of mental health issues and substance use among adolescents. 
Some examples include the Ontario Health Study which was a cross-
sectional community survey of children four to 16 years of age,33 two 
famous New Zealand cohorts with long term follow-up: Christchurch 
Health and Development Study34 and the Dunedin Multidisciplinary Health 
and Development Study,35 and the Early Developmental Stages of Psycho-
pathology Study that is following youth from Munich, Germany and 
surrounding areas over time and whose design features include linkage 
with a family supplement and neurobiological laboratory studies of high-
risk subjects.36
Assessment issues
There are various approaches to assessing mental health conditions among 
youth; using instruments based on taxonomy or symptom scales. A psych-
iatric disorder diagnosed via the ICD or DSM schema requires specific 
criteria and signs of impairment. Issues can arise in how different studies 
apply and operationalize the criteria (not to mention that the DSM criteria 
have changed over time). For example, the NCS-A study has been criticized 
for using substance abuse symptoms to screen for dependence; as a result, 
it does not capture information on youth who meet criteria for dependence 
but never met criteria for abuse.37 Also worth noting is that meeting disorder 
criteria does not necessarily imply functional impairment nor capture a 
severity threshold. On the other hand, clinically significant symptoms 
below the count necessary to warrant a diagnosis can be associated with 
functional impairment and are often the precursor of an emerging disorder 
and subthreshold diagnoses of substance use problems have been associated 
with psychiatric symptoms.38,39
Other common approaches used to screen for psychopathology among 
youth utilize lists of symptoms that often map onto DSM criteria.40 Instead of 
classifying the presence or absence of a diagnosis, symptom scales are used 
to rank the probability of having emotional and behavioral problems that 
might require further evaluation, clinical services or preventive inter ventions. 
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Though only approximating a psychiatric diagnosis, they may be useful in 
detecting syndromes and subclinical symptoms. Studies using data obtained 
from one such tool, the Youth Self-Report (YSR) developed by Achenbach,41 
find emotional and/or behavioral problems to be associated with substance 
use.42-44 Problem behaviors have also been associated with a rapid 
development of nicotine dependence among youth who recently initiated 
smoking45 and with both single and multiple SUDs in early adulthood.46 
It takes time and resources to assess a variety of psychiatric and SUDs. 
The number and array of diagnoses one wishes to assess accurately creates 
challenges for the design and administration and adds to the respondent 
burden. Lay interviewers can administer structured instruments to assess 
psychiatric disorders but training is required. Assessing the various sub-
stances youth can become involved in, especially as they become older and 
have increased opportunities and access to illicit as well as non medical 
prescription type drugs, as well as mapping abuse and dependence criteria 
for each substance type can easily become daunting. Many studies, instead 
of describing SUD ascribed to specific substances, use an ‘any’ SUD 
approach. However, the choice of what substance one uses to define the 
SUD may influence comorbidity patterns as different substances have 
different effects (e.g., stimulant versus depressive) and the reasons for use 
may also vary between individual (e.g., seeking a high versus self med-
icating). Comorbid associations between SUDs and externalizing disorders 
are often the strongest and the association between marijuana dependence 
and other psychiatric disorders is often weaker than those with alcohol or 
other drugs.19 Because of the low prevalence of many specific psychiatric 
disorders as well as SUDs resulting from certain substances, large sample 
sizes are needed for such specificity. 
A controversial point in assessing substance use and psychiatric dis orders 
is whether it is sufficient to rely only on adolescent self-reports. A youth’s 
knowledge of their own behavior and emotions makes them a potentially 
important contributor to the assessment process; however, comorbidity 
patterns among emotional and behavioral syndromes have been found to 
vary with the informant and there may be differential reporting by parents 
and youth by ethnic groups.19,47 Studies may use different informant sources 
such as parent reports only, youth report only, or a combination. Algorithm 
diagnoses cannot replace clinical judgment of the significance and impairment 
attributed to the diagnoses, but studies suggest that the general patterns of 
comorbidity are not affected by whether the data is put together by a clinician 
or by means of a computer algorithm scoring a structured interview.21 
Regardless of who the respondent is, another concern is how well does 
one distinguish and recall symptoms (potentially overlapping ones) over time. 
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Recall is also an extremely important limitation to establishing a greater 
understanding of the temporal sequencing, persistence and even re- 
occurrence of disorders. To avoid recall bias and have more immediate 
clinical relevance for treatment purposes, assessments tend to capture 
symptom experiences over a short time frame (i.e., a point prevalence of 
previous 30 days, 3 month or 12 month period). Surveys, on the other hand, 
often inquire about cumulative lifetime experiences. Retrospective recall 
bias may be less of an issue among adolescents because they are reflecting 
back upon fewer accumulated years of life than adults, but special probes 
as those used in the NCS-A that have been found to help increase recall 
among adults might still be useful in helping the youth to recall their 
experiences more reliably.48
Another cautionary note relates to a limitation of the term comorbidity, 
as it does not distinguish between a multitude of different temporal 
relationships among disorders. Angold and colleagues suggested different-
iating concurrent from successive comorbidity.14 In concurrent comorbidity, 
even if the time of onset and offset are not coterminous, the disorders must 
have at some point in time been present concurrently (or if not in time in 
phenomenology). This type of comorbidity is often captured in studies that 
have assessed point (current) prevalence. On the other hand, studies assessing 
lifetime prevalence may not determine if the disorders ever occurred 
simultaneously, suggesting that the term successive comorbidity may be 
more appropriate. Thus, when comparing results across studies comorbidity 
rates can be very different, probably because lifetime comorbidity although 
capturing a longer time period relays heavily on recall. However, lifetime 
prevalence based on retrospective age-of-onset reports from cross sectional 
studies may be used to help capture the development of comorbidity by 
distinguishing the onset versus the per sistence of the disorders.17An even 
stronger design would be to study the temporal sequencing of lifetime and 
current disorders in a longitudinal cohort of adolescents as with the Early 
Developmental Stages of Psycho pathology Study.49 
Finally, caution must also be taken not to artificially elevate the rates for 
psychiatric disorders because of a tendency to establish a diagnosis before 
some of the psychiatric symptomatology secondary to the substance use 
abates. A diagnosis of a substance-induced mental disorder may be averted 
by observing the adolescent for a minimum of four weeks after discontinuing 
drug use. For example, cocaine-induced states need to be clearly differ-
entiated from schizophrenia, mood disorders, and anxiety disorders. Ruling 
this out may be difficult for adolescents to establish on their own when they 
are self reporting symptoms on a survey with fewer probes than what might 
occur in a clinical assessment as they may not recognize the connection.
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As seen from the brief review of research issues above, the complexity 
of the subject matter increases the need for sophistication in how we study 
and understand it. It does not necessarily mean the literature is flawed, but 
caution should be taken when making inferences and generalizations based 
upon findings from different studies. Instead of relying on deductions about 
the onset of comorbidity obtained from adult studies fraught with recall 
biases, we need to obtain a clearer picture of what is happening during the 
developmental stages of youth as symptoms and behaviors onset to 
determine trajectories of persistence and severity. Evidence already 
suggests there are specific features of substance use and the psychiatric 
condition that merit attention and detailed prospective monitoring. There-
fore, future research should, whenever possible, focus on longitudinal 
study designs that start collecting data in early childhood of representative 
samples of youth in order to disentangle premorbid pathways that lead to 
comorbid SUD and psychiatric disorders.
Research Evidence
Next our review highlights some of the evidence on the magnitude and the 
kinds of co-occurring psychiatric and SUDs reported in some selected 
clinical samples as well as population-based studies of adolescents. A 
search of the PubMed, PsychInfo and Scopus databases identified several 
clinical and general population studies published in the past 15 years that 
specifically included adolescent samples with comorbid substance use and 
psychiatric disorders. Search terms included specific internalizing and 
externalizing disorders (e.g., ADHD, anxiety, depression) and SUD 
(including substance abuse, substance dependence, drug abuse, drug 
dependence, alcohol abuse, alcohol dependence). A preference was given 
for studies using diagnoses obtained via structured interviews and epi-
demiologic studies that used probability/representative sampling. In 
addition, because our main focus was on SUDs, studies focusing on 
comorbid substance use/drug use and psychiatric disorders were excluded. 
We observed a tendency for some research teams to strictly focus (or at 
least only publish) on either externalizing or internalizing disorders, not 
always both, as well as often limiting the assay of substance disorder to the 
more commonly used substances (e.g., alcohol and cannabis). 
Globally, national estimates of the overall occurrence of comorbidity 
are generally lacking as not all studies of adolescent samples focus on one 
of the comorbid disorders being SUDs per se, nor are structured diagnostic 
assessments routinely used to assess both the substance use and mental 
health status. In the US, the Oregon Adolescent Depression Project found 
that twice as many adolescents with a SUD also had a psychiatric disorder 
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(66.2%) compared to those with a psychiatric disorder who had a SUD 
(31.3%).50 More recently, the NCS-A study reported 40 percent of 
adolescents with one class of disorder also met criteria for another class of 
lifetime disorder.4 Hopefully, future publications of the NCS-A will provide 
greater distinction of specific comorbid patterns as the 40 percent is likely 
an over estimation of the kind of comorbidity we are focusing on (substance 
use and psychiatric disorders), as comorbidity between other internalizing 
and externalizing disorders where SUDs are not present also occurs. In the 
meantime, findings from a study of a probability sample of youth enrolled 
in a health maintenance organization provide some interesting insights. 
The patterns of comorbidity suggest that the comorbid relationship between 
a SUD and psychiatric disorder may vary by the type of substance (e.g., 
less with marijuana), by the type of SUD (e.g., less with abuse versus 
dependence), and by the type of psychiatric disorder (e.g., strongest for 
behavioral disorders).19 Some of these patterns have also been seen in adult 
data and may also extend to subthreshold disorders as well.50,51 
The type of psychiatric paychopathology most commonly diagnosed in 
adolescents with SUDs are the externalizing disorders.53 Clinical studies 
document a high degree of co-occurrence of ADHD and CD among 
adolescent samples with SUDs (Table 1). Since many of the samples were 
derived from treatment programs a wide array of substances were included 
under the any SUD classification as youth having problems with one 
substance type often are using other substances as well. The sample variation 
in age, sex and other factors, such as racial mix, inner city versus rural setting, 
or type of program or center in which the research was performed result in a 
wide range of comorbid rates. However, these clinical studies indicate the 
importance of exploring subgroup variation. For example, gender differences 
were often greater among those with comorbid ADHD and alcohol disorder 
than with comorbid CD and alcohol disorder. Additionally, race/ethnicity 
differences were observed among youth with SUD, indicating that Whites, 
Hispanics, individuals of mixed race, and individuals endorsing “other” race 
exhibited greater rates of either ADHD or CD than did African Americans or 
American Indian/Alaskan Natives with SUD.
Congruent with findings from clinical studies, evidence from epi-
demiologic studies of various designs indicate the comorbidity between 
externalizing disorders and SUDs in adolescents exists in the general 
population as well (Table 2). These studies also show that in addition to 
ADHD and CD, oppositional defiant disorder (ODD) commonly co-occurs 
with SUD in the adolescent population. 22,54-58 Many of the SUD disorders 
are substance specific or the any SUD is based on the more commonly used 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































epidemiologic studies include information obtained from other informants 
when making diagnostic classifications. Evidence from several of the 
longitudinal studies analyzing the co-occurrence prospectively find that the 
onset of externalizing psychopathology tends to precede the development 
of SUDs.34,59,60
In addition to descriptions of categorical classifications of externalizing 
psychopathology, a body of literature exists that describes how specific 
components or symptoms and personality traits are associated with sub-
stance use and SUDs in adolescence. In particular, many studies find that 
aggressive behavior, a component of CD, and violence accompany and 
often precede adolescent substance use and SUD.61-64 Additionally, 
impulsivity, one of the components of ADHD, is often associated with 
initiation of alcohol use in adolescence,65 while hyperactivity in childhood 
is associated with a greater likelihood of being arrested in young adulthood 
for charges stemming from illegal drug possession, use, and sale.66 Further-
more, it is possible that reciprocal relationships exist between psycho-
pathological symptoms and substance use behaviors, as certain drugs, such 
as alcohol, anabolic steroids, benzodiazepines, and cocaine can escalate the 
development of aggression and violent behavior.
Evidence of a high prevalence of a co-occurrence between internalizing 
disorders and SUDs is also shown in both clinical and epidemiologic 
studies.53,67 A review found evidence that comorbidity rates are higher in 
samples of adolescents where SUD appeared first than among youth where 
internalizing disorders preceded the onset of other disorders.67 Table 3 
provides some examples of clinical-based research where high rates of 
internalizing disorders, particularly MDD, are often found among ado-
lescent samples who are in treatment for SUDs. On the other hand, 
adolescents in treatment for psychiatric disorders also have comorbid 
SUDs.68 Modest rates of anxiety disorders, especially posttraumatic stress 
disorder, are also often found among youths with SUDs, ranging from six 
percent to 38 percent.69,70 Studies also find comorbidity between SUD in 
adolescence and bipolar disorder.71,72 As seen in the clinical studies of 
externalizing disorders, the substances included in the disorder category 
vary across studies, as do sample characteristics. Gender differences were 
noted by a few of the studies where females tend to have higher rates of 
comorbidity between SUDs and internalizing disorders than males. 
Numerous epidemiologic studies find mood and anxiety disorders 
strongly associated with SUDs in more general population samples of 
adolescence (Table 4). In many of these studies the SUD disorders are 
substance specific but in some studies the SUD includes other illegal drugs 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































were included. A few of the studies included information obtained from a 
caregiver in addition to reports by the adolescent when deriving disorder 
classifications. Many of the longitudinal studies indicate that the onset of 
internalizing disorders precedes the onset of SUDs,22,73,74 while others argue 
for reciprocal pathways between SUDs and internalizing disorders.58,75 
Late adolescence and early adulthood are also peak periods for the onset 
of other serious mental illnesses and abnormal/maladaptive behavior. 
Excessive use of drugs and/or alcohol are very common among youth with 
schizophrenia.76,77 Cannabis, amphetamine, cocaine, and to a lesser extent 
alcohol, are associated with psychosis.78-80 Eating disorders are frequently 
associated with substance use and are common among adolescents having 
SUDs.81,82 It has been speculated that young women with anorexia may 
initiate drug use in an effort to lose weight and that those with bulimia 
nervosa may be turning to substances to dampen purging symptoms and 
behaviors.83 SUDs and sleep disorders also often co-occur and have a 
significant negative effect upon normal development and are associated with 
deleterious effects on mood, attention, and behavior.84,85In addition, there is 
accumulating evidence from clinical and epidemiological studies on the link 
between drug use and suicide among adolescents,86,87 with comorbidity 
increasing the risk for suicidal behaviors.88 Alcohol abuse and dependence, 
cigarette smoking and cannabis use have been found to be associated with 
suicide attempts among adolescents.89,90 The intoxicating effects of drug use 
might lead to impairments in judgment or changes in mood which then 
increase risk for suicidal ideation and attempt91 and alcohol-specific effects 
such as disinhibition and emotional or behavioral problems (dysphoria, 
impulsivity, and aggression) have been implicated in suicidal behaviors.92 
While a goal of many studies is to make available evidence on the 
temporal order and sequencing of onset of substance use and disorder and 
the various psychiatric disorders, publications often do not include 
descriptives of the ages of onset. Table 5 summarizes the age of onset for 
major disorder groups described by several adolescent studies. Whereas 
sequencing can vary on an individual basis, the evidence appears to indicate 
that on average anxiety and behavior disorders precede SUDs, while there 
is less time differential between mood disorders and SUDs. On average, 
psychiatric disorders also precede nicotine dependence by at least two 
years.22,93,94 Paths to comorbidity have been noted to differ by sex.22 In 
addition, sensitivity to distinct trajectories may be warranted as externalizing 
disorders typically have onset in childhood or adolescence and then may 
persist into adulthood or decrease with age, while the onset of internalizing 
disorders occurs over the life course with their cumulative prevalence 
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Measure: Age first symptom Median ages Mean ages
Anxiety Disorder 3.8 6 10.7
Behavior Disorder 5 11 10.6
Mood Disorder 10.1 13 11.7
Substance Abuse/
Dependence
14.5 14-15*  14.7**
* Includes Alcohol and other drugs.
** Tobacco dependence.
In summary, numerous studies establish a comorbid association, but 
population estimates of how many, the when, and which youth are affected 
are scarce. In addition, more childhood and adolescent studies on the 
sequencing of the disorders, as well as how and the conditions under which 
the behaviors and mood conditions develop, are needed to obtain a greater 
understanding of the trajectories that will inform opportunities for pre-
vention and intervention.
Possible explanations
There are several possible explanations of why there is a connection 
between substance use and mental illness. Empirical research supports the 
existence of risk factors from multiple domains hypothesized in the social 
development model,95 such as one’s individual attributes, attitudes and 
opportunities, family or household structure and recent life events. Problem 
behavior syndrome and an array of complementary conceptual models link 
externalizing type behaviors such as aggression, rule breaking, and other 
socially maladaptive behaviors with tobacco use and drug-taking.96-100
The co-occurrence adds a complexity to understanding the intricate 
relationship and etiology. Understanding the sequencing behind the high 
prevalence of co-occurrences of drug abuse and psychopathology is not 
simple; one cannot assume just because one appeared first that it caused the 
other. Often emotional and behavior problems are found to precede drug 
use.101-103 Externalizing behaviors have been associated with the progression 
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of drug use, whether progression in stage of use within a particular drug104 
or becoming involved with other drugs, such as marijuana and inhalants.105,106 
This suggests some youth may be using drugs to self medicate. However, 
evidence that drug use precedes mental health outcomes also exists. Sub-
stance use and drug-related problems have both been shown to relate to 
disruptive behavior diagnoses.107,108 Mood changes are a common feature 
during withdrawal from several drugs of abuse.109 The shared liabilities of 
drug use disorders and other mental illnesses may also be due to genetic as 
well as environmental influences.110-114 Family-genetic studies provide evi-
dence of linkage between depression and drug abuse and substance dis-
orders.115,116 Alterations in reward and motivational processes might play a 
central role in the manifestation of core symptoms of both drug and psych-
iatric disorders.117,119 
Many theories and models of comorbidity have been postulated. These 
models often include multiple domains and highlight that there may be 
several different mechanisms and routes leading to comorbidity. New 
collection efforts should also seek to incorporate genetic as well as 
environmental influences that may impact the onset of comorbidity and 
allow study of the complex genetic interactions between a wide array of 
environmental factors.
RECOMMENDATIONS
The presence of high co-occurrence of externalizing and internalizing dis-
orders among youth abusing drugs and alcohol deserves attention to detect 
and provide appropriate treatment and referral for these problems as the 
burden of this comorbidity is significant. Previous reviews of adolescent 
out comes found strong evidence that this comorbid combination was 
associated with truancy, rebelliousness, academic problems, and school 
drop out.14,24 In addition, other studies point to the added economic and 
psycho social burden of having comorbid disorders, and less overall well 
being, including higher levels of psychopathology, suicidal ideation, and 
greater functional impairment.19,120-122 Further substantiating the importance 
of the need for prevention and early intervention among the adolescent 
years is the continued impact of comorbidity on young adult roles and 
behaviors. Comorbidity has been found to be associated with arrests, 
continued drug use, and reductions in work productivity49,123 and among 
HIV-infected individuals with decreased odds of highly active antiretroviral 
therapy (HAART) utilization and viral suppression.124 Having both psych-
iatric and SUDs increases impairment and results in poorer prognosis.
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Complications of co-occurring disorders on treatment outcome are also 
well-documented, as the complexity of problems may impair an adolescent’s 
ability to effectively engage in treatment125 and can increase the rate and 
rapidity of relapse.126 Findings have shown that many substance abuse treat-
ment clients with less serious psychiatric disorders do well with traditional 
substance abuse treatment methods, while those with more serious 
psychiatric disorders need intervention modifications and additions to 
enhance treatment effectiveness.127 The US Center for Substance Abuse 
Treatment has published best-practice guidelines for treating and recognizing 
the high overlap of psychiatric disorders among both substance abuse and 
mental health treatment clients.127 
Pharmacological advances over the past few decades have produced 
more effective psychiatric medications with fewer side effects that allow 
individuals with serious and persistent psychopathology to participate in 
treatment instead of being institutionalized, thus increasing the demand for 
integrated treatment. However, the development of integrated treatment 
requires both an understanding of psychopathology and addiction and the 
means to integrate and modify traditional treatment approaches in both the 
mental health and addiction treatment fields.128 Several strategies found to 
have promise for dual treatment of substance use and psychiatric disorders 
include: Motivational Interviewing, Contingency Management, Cognitive-
Behavioral Therapy, Relapse Prevention, Assertive Community Treatment, 
and Intensive Case Management.127 Randomized control trials are beginning 
to provide evidence that pharmacologic and psychological interventions are 
effective.129,130 Research is providing information on client factors as well as 
treatment facility facilitators and barriers to strengthen the integrated dual 
disorder treatment model.131-134 Continuity of care is necessary to guide 
individuals between service systems and continuing support and aid obtained 
via self help approaches is needed in the community for long term success.
Understanding the complexity between psychopathology and drug 
abuse, including the sequencing between both, would help guide us to 
knowing what to target and when to intervene.135 For example, for a young 
adolescent with CD or ADHD who began using drugs at an early age, an 
intervention program could have an effect on future drug disorders by 
reducing current drug use, or by ameliorating current disruptive problem 
behaviors, or both. A program that targets only the drug use might have little 
effect on youth at risk for future SUDs because of their history of behavioral 
problems, while a program targeting only the behavioral problems might 
have little effect on youth put at risk because of their early drug use. An 
example of a universal behavioral intervention provided at a very young 
age, as children enter the educational system, that has been tested in 
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community randomized control trials has shown that non-pharma ceutical 
approaches of prevention may be possible. Teachers use classroom behavior 
management strategies to socialize children to the student role and reduce 
aggressive and disruptive behaviors. This strategy, the Good Behavior 
Game,136 has been found to lower the rate of school-based service use (being 
placed in a special school or special classroom for problems with behavior, 
feelings, or drug or alcohol; receiving special help in the regular classroom; 
and receiving other counseling or therapy in school)137 and reduce drug and 
alcohol abuse/dependence disorders, regular smoking, and antisocial 
personality disorder among males.138 Behavior-influence procedures offer a 
unique opportunity for the prevention of substance use and psychiatric 
disorders at a public-health level.139 
Studies pursuing influences and the identification of the mechanisms 
behind the high co-occurrence of SUDs and psychiatric disorders among 
youth are needed. We must continue to disentangle the complex temporal 
relationship. It is important to optimize the research design and methods in 
order to collect and analyze data that can make further contributions in 
depicting the interplay and sequencing of symptoms and disorder 
development.
SUMMARY
There is strong evidence from clinical and population based studies that 
SUDs co-occur with externalizing and internalizing disorders, as well as 
other serious mental health conditions among adolescents. The ramifications 
and consequences of having comorbid disorders, as opposed to unitary 
conditions of drug abuse separate from emotional and other behavioral 
problems, are complex. Traditional treatment and prevention approaches 
for adolescent well being require modifications to broaden their assessments 
to detect comorbid conditions. Not only should drug using adolescents be 
screened for psychopatholgy, but visa versa. In addition the identification 
and evaluation of comorbid disorders should not be limited to concurrency 
defined only by one point in time but take into consideration the history of 
drug involvement and mental health over the entire developmental lifespan. 
It is imperative that researchers continue to develop a better understanding 
of the co-occurrence (pre existing or consequential) of substance use and 
mental illness among youth in hopes of forestalling significant morbidity 
and mortality, such as disfunctionality or suicide.
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ADHD = attention-deficit/hyperactivity disorder
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CD = conduct disorder
DSM = Diagnostic and Statistical Manual of Mental Disorders
ICD = International Classification of Diseases
MDD = major depressive disorder
NCS-A = The National Comorbidity Survey-Adolescent Supplement
SUD = substance use disorder
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